Gujarat Inject Kerala Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 26-12-2023
- Paid Up Capital ₹ 4.88 Cr
as on 26-12-2023
- Company Age 33 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.30 M
as on 26-12-2023
- Satisfied Charges ₹ 4.00 Cr
as on 26-12-2023
About Gujarat Inject Kerala
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524238.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 4.88 Cr.
The company currently has active open charges totaling ₹4.30 M. The company has closed loans amounting to ₹4.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Gujarat Inject Kerala Ltd India is Murli Nair as CFO. Gautam Chauhan, Murli Nair, Reena Mahatma, and One other member serve as directors at the Company.
- CIN/LLPIN
L18100KL1991PLC005926
- Company No.
005926
- Stock Symbol
BSE : 524238
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Jan 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Palakkad, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gujarat Inject Kerala?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murli Nair  | CFO | 15-Jun-2019 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gautam Chauhan | Director | 04-Mar-2016 | Current |
| Murli Nair | Whole-Time Director and Cfo | 30-Sep-2015 | Current |
| Reena Mahatma | Director | 30-Sep-2015 | Current |
| Narayansinh Chauhan | Director | 04-Mar-2016 | Current |
Financial Performance of Gujarat Inject Kerala.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gujarat Inject Kerala?
Unlock access to Gujarat Inject Kerala's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Shankheshwer Wind Power Developers Private LimitedActive 11 years 11 months
Reena Mahatma is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Federal Bank Ltd. Creation Date: 21 May 1993 | ₹4.30 M | Open |
Ifci Limited Creation Date: 22 Mar 1993 | ₹1.08 Cr | Satisfied |
Ifci Limited Creation Date: 20 Feb 1992 | ₹2.92 Cr | Satisfied |
How Many Employees Work at Gujarat Inject Kerala?
Unlock and access historical data on people associated with Gujarat Inject Kerala, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gujarat Inject Kerala, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gujarat Inject Kerala's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
